{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:49:11Z","timestamp":1782942551649,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cellimm.2023.104779","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T23:55:52Z","timestamp":1698623752000},"page":"104779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Genetic deficiencies of both IL-4 receptor alpha chain and IL-10 trigger early onset of severe colitis in mice"],"prefix":"10.1016","volume":"393-394","author":[{"given":"Hisashi","family":"Nagase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Takamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Noben-Trauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2023.104779_b0005","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.3748\/wjg.v18.i41.5848","article-title":"Changes of the cytokine profile in inflammatory bowel diseases","volume":"18","author":"M\u0171zes","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellimm.2023.104779_b0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.20.100301.064816","article-title":"The immunology of mucosal models of inflammation","volume":"20","author":"Strober","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2023.104779_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169344","article-title":"Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease","volume":"23","author":"Katsandegwaza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2023.104779_b0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2023.104779_b0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1749-6632.2011.06339.x","article-title":"IL-10 and IL-10 receptor defects in humans","volume":"1246","author":"Glocker","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cellimm.2023.104779_b0030","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.cellimm.2023.104779_b0035","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.1085458","article-title":"Interleukin-4 and interleukin-13 signaling connections maps","volume":"300","author":"Kelly-Welch","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2023.104779_b0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3476","article-title":"Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths","volume":"13","author":"Gause","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2023.104779_b0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.187.3.307","article-title":"Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans","volume":"187","author":"Mencacci","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2023.104779_b0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.micinf.2005.09.006","article-title":"Induction of chronic colitis in IL-10 deficient mice requires IL-4","volume":"8","author":"Specht","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cellimm.2023.104779_b0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.gene.6363782","article-title":"Dextran sulphate sodium-induced colitis is ameliorated in interleukin 4 deficient mice","volume":"2","author":"Stevceva","year":"2001","journal-title":"Genes Immun."},{"key":"10.1016\/j.cellimm.2023.104779_b0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","article-title":"Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells","volume":"17","author":"Heller","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2023.104779_b0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2010.09.047","article-title":"Colitis and intestinal inflammation in IL10-\/- mice results from IL-13R\u03b12-mediated attenuation of IL-13 activity","volume":"140","author":"Wilson","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellimm.2023.104779_b0070","doi-asserted-by":"crossref","first-page":"10838","DOI":"10.1073\/pnas.94.20.10838","article-title":"An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice","volume":"94","author":"Noben-Trauth","year":"1997","journal-title":"PNAS"},{"key":"10.1016\/j.cellimm.2023.104779_b0075","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1128\/IAI.66.11.5157-5166.1998","article-title":"Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism","volume":"66","author":"Kullberg","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2023.104779_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.20021345","article-title":"CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms","volume":"197","author":"Maloy","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2023.104779_b0085","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.4049\/jimmunol.170.8.3939","article-title":"Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells","volume":"170","author":"Mottet","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104779_b0090","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00069.2006","article-title":"Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells","volume":"291","author":"Khan","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cellimm.2023.104779_b0095","doi-asserted-by":"crossref","first-page":"G829","DOI":"10.1152\/ajpgi.2000.278.6.G829","article-title":"Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-\/-) mice and intestinal inflammation","volume":"278","author":"Rennick","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cellimm.2023.104779_b0100","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.241258698","article-title":"A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice","volume":"98","author":"Farmer","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.cellimm.2023.104779_b0105","doi-asserted-by":"crossref","first-page":"eaba4376","DOI":"10.1126\/sciadv.aba4376","article-title":"Human interleukin-4-treated regulatory macrophages promote epithelial wound healing and reduce colitis in a mouse model","volume":"6","author":"Jayme","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cellimm.2023.104779_b0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/21505594.2019.1573050","article-title":"Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells","volume":"10","author":"Sharba","year":"2019","journal-title":"Virulence"},{"key":"10.1016\/j.cellimm.2023.104779_b0115","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.4049\/jimmunol.166.4.2793","article-title":"IL-4 exacerbates disease in a Th1 cell transfer model of colitis","volume":"166","author":"Fort","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104779_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.573470","article-title":"Interleukin-4 Receptor \u03b1 Subunit Deficiency Alleviates Murine Intestinal Inflammation In Vivo Through the Enhancement of Intestinal Mucosal Barrier Function","volume":"11","author":"Hertati","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellimm.2023.104779_b0125","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/379821a0","article-title":"Mapping of a susceptibility locus for Crohn's disease on chromosome 16","volume":"379","author":"Hugot","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2023.104779_b0130","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/hmg\/5.10.1679","article-title":"Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis","volume":"5","author":"Ohmen","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cellimm.2023.104779_b0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/jmg.35.3.218","article-title":"Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis","volume":"35","author":"Mirza","year":"1998","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cellimm.2023.104779_b0140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2023.104779_b0145","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2023.104779_b0150","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00054725-200405000-00019","article-title":"Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field","volume":"10","author":"Brant","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cellimm.2023.104779_b0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1073\/pnas.261567999","article-title":"Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p","volume":"99","author":"Hampe","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.cellimm.2023.104779_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002510050001","article-title":"Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease","volume":"51","author":"Olavesen","year":"2000","journal-title":"Immunogenetics"},{"key":"10.1016\/j.cellimm.2023.104779_b0165","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/sj.ejhg.5201058","article-title":"No evidence for involvement of IL-4R and CD11B from the IBD1 region and STAT6 in the IBD2 region in Crohn's disease","volume":"11","author":"de Jong","year":"2003","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cellimm.2023.104779_b0170","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.4049\/jimmunol.177.9.5852","article-title":"Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis","volume":"177","author":"Uhlig","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104779_b0175","doi-asserted-by":"crossref","unstructured":"A.M. Vlk, D. Prantner, K.A. Shirey, D.J. Perkins, M.S. Buzza, V. Thumbigere-Math, A.D. Keegan, S.N. Vogel, M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice, mBio, (2023) e0120823.","DOI":"10.1128\/mbio.01208-23"},{"key":"10.1016\/j.cellimm.2023.104779_b0180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14728222.2021.1901079","article-title":"Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease","volume":"25","author":"Du","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cellimm.2023.104779_b0185","doi-asserted-by":"crossref","first-page":"1155077","DOI":"10.3389\/fimmu.2023.1155077","article-title":"A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104779_b0190","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.celrep.2019.03.028","article-title":"YAP Aggravates Inflammatory Bowel Disease by Regulating M1\/M2 Macrophage Polarization and Gut Microbial Homeostasis","volume":"27","author":"Zhou","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2023.104779_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.649463","article-title":"Tiliroside Ameliorates Ulcerative Colitis by Restoring the M1\/M2 Macrophage Balance","volume":"12","author":"Zhuang","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874923001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874923001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:15:29Z","timestamp":1757805329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874923001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"alternative-id":["S0008874923001181"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104779","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic deficiencies of both IL-4 receptor alpha chain and IL-10 trigger early onset of severe colitis in mice","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104779"}}